AF
PVLA

Allworth Financial’s Palvella Therapeutics PVLA Stock Holding History

Allworth Financial’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.12K Buy
17
+12
+240% +$1.25K ﹤0.01% 4336
2025
Q4 		$524 Hold
5
– – ﹤0.01% 4516
2025
Q3 		$314 Hold
5
– – ﹤0.01% 4538
2025
Q2 		$113 Hold
5
– – ﹤0.01% 4387
2025
Q1 		$128 Hold
5
– – ﹤0.01% 3931
2024
Q4 		$66 Hold
5
– – ﹤0.01% 3861
2024
Q3 		$83 Hold
5
– – ﹤0.01% 3668
2024
Q2 		$37 Buy
5
+1
+25% +$11 ﹤0.01% 3636
2024
Q1 		$65 Hold
4
– – ﹤0.01% 3524
2023
Q4 		$64 Hold
4
– – ﹤0.01% 3362
2023
Q3 		$105 Hold
4
– – ﹤0.01% 3342
2023
Q2 		$58 Hold
4
– – ﹤0.01% 3188
2023
Q1 		$342 Buy
+4
New +$463 ﹤0.01% 2914

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return